New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
9th May 2023
Chile: The Chamber of Deputies yesterday approved Bill 12626-11, which together with Bill 12632-11 seeks to equate all vaping products, regardless of their nicotine content, with tobacco products, regulating their sale, advertising and labelling. The bill was introduced four years ago, and received Senate approval in March 2021. However, it needs to be approved again by the Senate since the Chamber of Deputies proposed several modifications. Should the bill be approved, nicotine-containing vaping products will no longer be subject to the pharmaceutical regime.
25th November 2022
9th November 2022
Chile: The Chamber of Deputies Health Committee yesterday heard the government’s comments on Bill 12626-11, which, together with Bill 12632-11, seeks to equate all vaping products, regardless of their nicotine content, with tobacco products. The Health Committee agreed in March to drop all provisions relating to vaping products, but they have been reintroduced. The committee has now set a new deadline of 17th November to end the discussion and decide on the bill, which also introduces certain provisions on e-cigarette devices and their components.
26th August 2022
17th August 2022
Chile: Bill 12694-11 to establish a comprehensive regulatory framework for vaping products, with and without nicotine, has recently been on the agenda of the Chamber of Deputies Health Committee, having been in the legislative process since June 2019. Though scheduled debates on 2nd, 9th and 16th August failed to take place, the mere fact of the bill’s first appearance on the agenda may suggest a willingness to start pushing it forward. One of the signatories to the bill, Gabriel Boric, became Chile’s president in March.
14th April 2022
Chile: The Public Health Institute (ISP) has warned against the use of e-cigarettes, with a reminder that those containing nicotine are illegal in Chile as the ISP has not granted the required pharmaceutical status to any such product. The institute also says nicotine-free vaping products pose multiple health risks.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.